SCHEMBL6567563

SCHEMBL6567563

O=C(Nc1cc(Cl)c(O)c(Cl)c1)Nc1ccccc1-c1ccccc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 2/20 0.54
CA1 P00915 2/20 0.54
CA2 P00918 2/20 0.54
CA9 Q16790 2/20 0.54
KMT2A Q03164 8/20 0.52
MAPT P10636 8/20 0.52
MEN1 O00255 7/20 0.52
RAB9A P51151 6/20 0.52
NPC1 O15118 5/20 0.52
POLB P06746 3/20 0.52
GAA P10253 2/20 0.52
KDM4E B2RXH2 3/20 0.51
NPSR1 Q6W5P4 3/20 0.51
MAPK1 P28482 1/20 0.51
TDP1 Q9NUW8 1/20 0.51
LMNA P02545 5/20 0.50
ALDH1A1 P00352 3/20 0.50
SMN1; SMN2 Q16637 2/20 0.50
TTR P02766 1/20 0.50
NFKB1 P19838 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3668804 0.82 CNR1 (0.61) KMT2AMAPTMEN1RAB9ANPC1
SCHEMBL29776946 0.81 CA12 (0.70) CA12CA1CA2CA9KMT2A
SCHEMBL4342381 0.81 KMT2A (0.68) KMT2AMAPTMEN1RAB9ANPC1
SCHEMBL34420050 0.81 CA12 (0.64) CA12CA1CA2CA9KMT2A
SCHEMBL3787717 0.80 CXCR2 (0.66) CA12CA1CA2CA9KMT2A
SCHEMBL4343434 0.79 DDX3X (0.65) CA12CA1CA2CA9KMT2A
SCHEMBL3681281 0.79 MGLL (0.73) KMT2AMAPTMEN1RAB9ANPC1
SCHEMBL5595432 0.79 RET (0.56) CA12CA1CA2CA9KMT2A
SCHEMBL6567241 0.78 EPHX1 (0.59) CA2CA9KMT2AMAPTMEN1
SCHEMBL4345909 0.77 KDM4E (0.66) KMT2AMAPTMEN1RAB9ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1402887-A1 New compounds for the inhibition of undesired cell proliferation and use thereof Jerini AG (DE) 2004-03-31 EP claimed
EP-1402888-A1 The use of substituted carbocyclic compounds as rotamases inhibitors Jerini AG (DE) 2004-03-31 EP claimed